With the global pandemic leading to a big rise in mental health issues, medtech could have a role to play. In this first part of a two-part series focusing on mental health tech, Medtech Insight focuses on transcranial magnetic stimulation systems used to treat severe anxiety and depression, among other indications. Part two will focus on the skyrocketing use of telehealth, apps and light therapy.   

In this week’s podcast, Medtech Insight's managing editor Marion Webb chats with editor-in-chief Phil Greenfield about start-up Protaryx Medical, which raised $8.3m to develop a universal catheter system for delivering beating heart treatments. Deputy editor Reed Miller discusses proposed updates by the Centers for Medicare and Medicaid Services for coverage of transcatheter mitral valve repair and reporter Catherine Longworth talks about her Exec Chat on digital transformation in health care with Boston Scientific's Angelo De Rosa. 

Medtronic said its newly US FDA-approved Percept deep brain stimulation system will first be used at the Mayo Clinic in Rochester, MN.

Guardant Health presented new clinical data at this week’s American Association for Cancer Research conference and outlined its growth plans as cancer testing volumes recover after the pandemic.

This week's Device Week podcast covers the recent American Diabetes Association conference, which was held online for the first time. The major diabetes device makers – Abbott, Medtronic and Dexcom – used the meeting to announce new clinical data and explain their diabetes product pipeline to customers and investors.

After announcing positive results at the American Diabetes Association conference and an expanded FDA approval for its insulin pump delivery system, Tandem Diabetes Care’s CEO outlines its path forward.